Nifoxipam
Structural formula | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General | |||||||||||||
Surname | Nifoxipam | ||||||||||||
other names |
|
||||||||||||
Molecular formula | C 15 H 10 FN 3 O 4 | ||||||||||||
Brief description |
crystalline solid |
||||||||||||
External identifiers / databases | |||||||||||||
|
|||||||||||||
properties | |||||||||||||
Molar mass | 315.26 g mol −1 | ||||||||||||
safety instructions | |||||||||||||
|
|||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Nifoxipam is a chemical compound from the benzodiazepine group and a metabolite of flunitrazepam . The compound has been marketed as a research chemical since 2014 .
Nifoxipam can be identified by gas chromatography with mass spectrometry coupling . The compound showed a tranquillizing (fight test) and a sleep-prolonging effect with a significantly lower toxicity than comparison substances.
Individual evidence
- ↑ a b c Maria Katselou, Ioannis Papoutsis, Panagiota Nikolaou, Chara Spiliopoulou, Sotiris Athanaselis: Metabolites replace the parent drug in the drug arena. The cases of fonazepam and nifoxipam. In: Forensic Toxicology. 35, 2017, p. 1, doi : 10.1007 / s11419-016-0338-5 .
- ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
- ↑ Google patent search: Patent EP0158267A2 - Medicines containing 5- (2-fluorophenyl) -1,3-dihydro-3-hydroxy-7-nitro ... - Google patent search , accessed on August 30, 2017.